FREGMA: Reliability and Reproducibility of Automated Angular Measurement in Strabismus

Sponsor
Nantes University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03596138
Collaborator
(none)
120
1
7.8
15.4

Study Details

Study Description

Brief Summary

Angular measurement of deviation is an essential element in the clinical evaluation of strabic patients. It is performed by orthoptic methods. However, studies show that the same patient presents a great variability of his angular measurement between 2 consultations, and between 2 observers.

Automated angle measurement is a recent concept that aims to overcome the defects of subjective angle measurement by alternate occlusion test and prismatic bar.

Improvements made by these devices would provide reliable, objective and reproducible measurements of the angle of deviation by increasing the accuracy of strabal angle assessment, improving decision making and surgical follow-up, decreasing inter-examiner variability and variability over time, and facilitating data comparison to improve scientific publication possibilities.

The Gazelab® device is a video-oculograph combined with a laser projection system and an infrared camera. It allows an objective angular evaluation, in non-dissociating physiological conditions, possible even in the absence of binocular vision and allows an analysis of the deviation in all positions.

There is extremely little data in the literature on automated measuring devices. The Gazelab tool is still little known in the strabology discipline and seems to have a number of advantages over other devices. The interest of this examination towards this pathology led the ophthalmology department to use it in the current practice, and since recently it is an act nomenclaturé.

Condition or Disease Intervention/Treatment Phase
  • Other: Evaluate the reliability and reproductibility of the automated angular measurement by the Gazelab

Detailed Description

The objective of this work is to evaluate the reliability and reproducibility of the automated angular measurement by the Gazelab® (ES12/13127) apparatus, compared to the standard gold which is the angular measurement by alternate occlusion test and prismatic bar, in horizontal strabisms (converging and diverging). Indeed in our daily practice the 2 examinations are carried out. To compare with the standard gold which denotes a strong inter-observer variability, the investigator will compare the results of the Gazelab to the alternate occlusion by prism bar (standard gold) 2 times with 2 trained examiners

Study Design

Study Type:
Observational
Actual Enrollment :
120 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Reliability and Reproducibility of Automated Angular Measurement in Strabismus
Actual Study Start Date :
Sep 4, 2018
Actual Primary Completion Date :
Apr 29, 2019
Actual Study Completion Date :
Apr 29, 2019

Outcome Measures

Primary Outcome Measures

  1. Intra-class correlation coefficient [12 months]

    Intra-class correlation coefficient calculated on the 4 measures (2 of each technique) of each patient taken at time 1 by the same assessor.

Secondary Outcome Measures

  1. Intra-class correlation coefficient using measurements [12 months]

    Intra-class correlation coefficient using measurements from each technique between 2 different evaluators at time 1

  2. Intraclass correlation coefficient using time 1 and time 2 measurements [12 months]

    Intraclass correlation coefficient using time 1 and time 2 measurements with the same investigator

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients over 18 years of age

  • Strabic convergent or divergent patients or patients requiring an oculomotor check-up in their follow-up consultation

  • Patient giving oral consent to this study

Exclusion Criteria:
  • Patient with medical follow-up impossible,

  • Impossibility to install Gazelab equipment for anatomical reasons of the head (craniostenosis...)

  • No ocular fixation.

  • Major without freedom under guardianship or trusteeship

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Nantes Nantes France 44000

Sponsors and Collaborators

  • Nantes University Hospital

Investigators

  • Principal Investigator: Pierre LEBRANCHU, Dr, CHU Nantes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT03596138
Other Study ID Numbers:
  • RC18_0062
First Posted:
Jul 23, 2018
Last Update Posted:
Sep 13, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nantes University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2021